[Hypercalcemia in liver tumors (author's transl)]

Area of Science:

• Oncology
• Endocrinology
• Hepatology

Background:

• Hypercalcemia is a complex metabolic disturbance that can complicate the course of primary liver tumors.
• Understanding the diverse etiologies of hypercalcemia is essential for effective patient management.

Observation:

• This study evaluated 32 patients with primary liver tumors to determine the incidence and causes of hypercalcemia.
• Identified causes included osteolytic metastases (2 patients), coexistent primary hyperparathyroidism (1 patient), and a paraneoplastic syndrome (1 patient).
• Two complex cases are detailed, highlighting diagnostic challenges in debilitated patients where invasive procedures are limited.

Findings:

• Hypercalcemia in primary liver tumors stems from various factors, necessitating thorough differential diagnosis.
• Mithramycin is identified as a potent treatment for acute hypercalcemic syndrome.
• Surgical resection of the primary liver tumor or parathyroid adenoma is recommended when feasible.

Implications:

• The findings underscore the importance of a systematic approach to diagnosing hypercalcemia in liver cancer patients.
• Effective management strategies involve both medical treatment and surgical intervention when appropriate.
• Further research into paraneoplastic mechanisms and novel therapeutic targets is warranted.